HOME >> BIOLOGY >> NEWS
Carnegie Mellon, NASA to develop robot illustrating how to seek life on distant planets

oring Mars."

In addition to Wettergreen, the Carnegie Mellon team heading to the Atacama includes William L. "Red" Whittaker, the Robotics Institute's Fredkin research professor and the project's principal investigator; Alan S. Waggoner, professor of biological sciences and director of Molecular Biosensor and Imaging Center; James P. Teza, research engineer; Michael D. Wagner, research programmer, and Robotics Institute doctoral students Christopher Urmson, Paul Tompkins, Denis Strelow and Vandi Verma.

Nathalie Cabrol, a planetary scientist at NASA's Ames Research Center and the SETI Institute, will lead the science team for the investigation of the Atacama. Members of the science team are geologists and biologists who study both Earth and Mars at institutions including NASA Ames and the Johnson Space Center, SETI Institute, Jet Propulsion Laboratory, the University of Arizona, the University of Tennessee, Carnegie Mellon and Universidad Catolica del Norte (Chile).

"Their role in the first-year campaign will be to become acquainted with the data sent by the rover and assess the validity of astrobiological exploration strategies that will be used in the 2004 and 2005 field campaigns and on future missions to search for habitats and life on Mars," said Cabrol.

Also under development is the capability for education and science communities to experience the mission through the EventScope interface (www.eventscope.org). EventScope converts data from rovers and orbiters into three-dimensional "virtual worlds" that realistically represent remote sites, enabling students to experience the mission from their classroom computers.

EventScope's team is directed by Peter Coppin, a research scientist at Carnegie Mellon's STUDIO for Creative Inquiry, and includes experts in software engineering, interactive art and educational technology working to develop next generation tools for public remote experience. The goal is to have hundreds of
'"/>


1-Apr-2003


Page: 1 2 3 4

Related biology news :

1. Carnegie Mellon researcher tests tools for protecting Anacostia River ecosystem from PCBs
2. Carnegie Mellon scientists reveal ways of studying, resolving PCB contamination in US rivers
3. PCB breakdown in rivers depends on sediment-specific bacteria, find Carnegie Mellon U. scientists
4. Carnegie Mellon researchers to demonstrate autonomous robotthat will seek life in Atacama Desert
5. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
6. Carnegie Mellon neuroscientist develops tool to image brain function at the cellular level
7. Carnegie Mellon U. imaging study reveals sex-based differences that persist as mice enter adulthood
8. Carnegie Mellon computational biologist Russell Schwartz receives prestigious CAREER award
9. Carnegie Mellon U biologists identify critical player in yeast ribosome assembly
10. Carnegie Mellon U. develops microgel to recover enzymes for manufacturing, research assays
11. Carnegie Mellon U. conducts first comprehensive proteomic analysis of developing animal

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ACEA Biosciences, ... its Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer ... providing an update on the phase I/II clinical trials for AC0010 in patients with ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only way to ... technology experience. All three tenets were on display at the 2nd Annual DrugDev User ... 40 sponsor, CRO and site organizations to discuss innovation and the future of clinical ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
(Date:11/30/2016)... Nov. 30, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" ... PBT.U), is excited to announce the formation of ... developing preclinical ophthalmology assets through proof of concept. ... created by Portage Pharmaceuticals Limited and being developed ... surface and anterior segment diseases. This agent has ...
Breaking Biology Technology:
Cached News: